Sagent Pharmaceuticals Reports Third Quarter 2012 Financial Results

[at noodls] – Record Revenue and Product Approvals Drive Improved Performance SCHAUMBURG, Ill., Nov. 8, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced financial results for the quarter … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard